Detalhe da pesquisa
1.
Daphnanes diterpenes from the latex of Hura crepitans L. and their PKCζ-dependent anti-proliferative activity on colorectal cancer cells.
Bioorg Med Chem
; 90: 117366, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37329676
2.
Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial.
Lancet
; 385(9973): 1075-86, 2015 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25467591
3.
Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study.
HIV Clin Trials
; 17(2): 63-71, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27077673
4.
Use of direct-acting agents for hepatitis C virus-positive kidney transplant candidates and kidney transplant recipients.
Transpl Int
; 29(12): 1257-1265, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27717014
5.
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.
Gastroenterology
; 147(1): 132-142.e4, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24704719
6.
High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial).
Gastroenterology
; 141(1): 119-27, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21439960
7.
Low-dose peginterferon alfa-2a is safe and produces a sustained virologic response in patients with chronic hepatitis C and end-stage renal disease.
Clin Gastroenterol Hepatol
; 9(3): 242-8, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21056689
8.
Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: the HEPAIG study.
Hepatology
; 52(6): 1915-21, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21064156
9.
What are the management issues for hepatitis C in dialysis patients?: hepatitis C virus infection and its treatment in patients with end-stage renal disease.
Semin Dial
; 27(5): 451-5, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25204878
10.
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial.
Lancet Gastroenterol Hepatol
; 2(3): 177-188, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28404133
11.
Pegylation of IFN-alpha and antiviral activity.
J Interferon Cytokine Res
; 26(12): 849-53, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17238827
12.
Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.
PLoS One
; 11(10): e0162965, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27749916
13.
Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen - The ANRS CO20-CUPIC study.
Clin Res Hepatol Gastroenterol
; 39(4): 443-50, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25636238
14.
Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?
PLoS One
; 10(9): e0138091, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26394142
15.
Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN.
Am J Kidney Dis
; 43(4): 617-23, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15042538
16.
Convenient biological assay for polyethylene glycol-interferons in patients with hepatitis C.
Antimicrob Agents Chemother
; 48(9): 3610-2, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15328140